Patents by Inventor Long Long
Long Long has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12502216Abstract: A microwave ablation needle head and a microwave ablation needle are provided. The microwave ablation needle head comprises an outer tube, a cooling tube provided within and spaced apart from the outer tube, a coaxial cable, and an electrode. The outer tube comprises a first and a second branch tube sequentially provided from the outer tube's distal end to proximal end. The first branch tube has an end away from the second branch tube that forms the distal end of the outer tube, and is made of a ceramic material or a polymer material. A first cooling flow channel is formed between the cooling tube and the outer tube, the cooling tube is made of a polymer material, and the distal end of the cooling tube is located inside the distal end of the first branch tube, forming a mounting space in a distal end region of the cooling tube.Type: GrantFiled: April 8, 2020Date of Patent: December 23, 2025Assignee: CANYON MEDICAL INC.Inventors: Weizhong Wang, Long Long
-
Patent number: 12433241Abstract: The present disclosure relates to a device for live animal transport, comprising: a bottom plate, comprising a liquid guide plate and a non-liquid guide plate, wherein the liquid guide plate has a first end and a second end opposite the first end; a plurality of support members, symmetrically provided at predetermined intervals on the bottom plate at the first end and the second end of the liquid guide plate, and extending in a first direction perpendicular to the bottom plate; a plurality of pillars, one end of each pillar being nested in a corresponding one support member, and the plurality of pillars being capable of telescoping in the first direction; a plurality of beams, extending in a second direction from the first end of the liquid guide plate to the second end of the liquid guide plate, each beam being supported by the other end of the pillar at the first end of the liquid guide plate and the other end of the pillar at the second end of the liquid guide plate; side plates, provided on the bottom plaType: GrantFiled: May 29, 2024Date of Patent: October 7, 2025Assignee: The Boeing CompanyInventors: Jiao Mo, Ke Ma, Paola Trapani, Saverio Silli, Yiwei Liu, Jialin Yuan, Yuchen Tan, Jiyu Song, Kudilaiti Kuerban, Peizhong Gao, Long Long, Cynthia A. Vandewall
-
Patent number: 12247394Abstract: An inflatable partition includes a flexible membrane, an inflatable frame, and a support member coupled to the inflatable frame. The inflatable frame extends along a periphery of the flexible membrane and has an inner edge adjacent to the flexible membrane and an outer edge. The inflatable frame further includes a sealing mechanism extending along at least a portion of the outer edge and the inflatable frame is inflatable between a first state and a second state. The inflatable partition includes a first structural member and a second structural member. Each of the first and second structural members is coupled to the inflatable frame and extends vertically from the upper portion to the bottom portion of the inflatable frame and the first and second structural members define an opening in the inflatable partition.Type: GrantFiled: October 27, 2023Date of Patent: March 11, 2025Assignee: The Boeing CompanyInventors: Liu Weiqiang, Zhongzhe Dong, Long Long, Daniel Wei
-
Patent number: 12239305Abstract: Disclosed are a channel device for surgery and a trigger structure. It aims at improving the problem that the operational efficiency of existing channel devices for surgery is not high. The channel device for surgery includes: a binding cord configured to be wound around a metal net; and a binding wire configured to pass through the binding cord and tighten up the binding cord, so as to compress the metal net, or configured to be pulled away from the binding cord, so as to loosen the binding cord and the metal net. In the trigger structure, different first locking portions are configured to cooperate with a first engaging portion, so as to drive the trolley to slide intermittently relative to the handle, such that a second engaging portion cooperates with different second locking portions, hereby locking the sliding trolley in different positions on the handle.Type: GrantFiled: April 15, 2020Date of Patent: March 4, 2025Assignee: Micro-Tech Nuroway Co., Ltd.Inventors: Derong Leng, Zhuhai Lv, Wenqi Lv, Changqing Li, Long Long, Jianyu Wei, Chengwei Tang, Li Ding
-
Publication number: 20240415089Abstract: The present disclosure relates to a device for live animal transport, comprising: a bottom plate, comprising a liquid guide plate and a non-liquid guide plate, wherein the liquid guide plate has a first end and a second end opposite the first end; a plurality of support members, symmetrically provided at predetermined intervals on the bottom plate at the first end and the second end of the liquid guide plate, and extending in a first direction perpendicular to the bottom plate; a plurality of pillars, one end of each pillar being nested in a corresponding one support member, and the plurality of pillars being capable of telescoping in the first direction; a plurality of beams, extending in a second direction from the first end of the liquid guide plate to the second end of the liquid guide plate, each beam being supported by the other end of the pillar at the first end of the liquid guide plate and the other end of the pillar at the second end of the liquid guide plate; side plates, provided on the bottom plaType: ApplicationFiled: May 29, 2024Publication date: December 19, 2024Applicant: The Boeing CompanyInventors: Jiao Mo, Ke Ma, Paola Trapani, Saverio Silli, Yiwei Liu, Jialin Yuan, Yuchen Tan, Jiyu Song, Kudilaiti Kuerban, Peizhong Gao, Long Long, Cynthia A. Vandewall
-
Publication number: 20240060296Abstract: An inflatable partition includes a flexible membrane, an inflatable frame, and a support member coupled to the inflatable frame. The inflatable frame extends along a periphery of the flexible membrane and has an inner edge adjacent to the flexible membrane and an outer edge. The inflatable frame further includes a sealing mechanism extending along at least a portion of the outer edge and the inflatable frame is inflatable between a first state and a second state. The inflatable partition includes a first structural member and a second structural member. Each of the first and second structural members is coupled to the inflatable frame and extends vertically from the upper portion to the bottom portion of the inflatable frame and the first and second structural members define an opening in the inflatable partition.Type: ApplicationFiled: October 27, 2023Publication date: February 22, 2024Applicant: The Boeing CompanyInventors: Liu Weiqiang, Zhongzhe Dong, Long Long, Daniel Wei
-
Patent number: 11885123Abstract: An inflatable partition includes a flexible membrane, an inflatable frame, and a support member coupled to the inflatable frame. The inflatable frame extends along a periphery of the flexible membrane and has an inner edge adjacent to the flexible membrane and an outer edge. The inflatable frame further includes a sealing mechanism extending along at least a portion of the outer edge and the inflatable frame is inflatable between a first state and a second state. The inflatable partition includes a first structural member and a second structural member. Each of the first and second structural members is coupled to the inflatable frame and extends vertically from the upper portion to the bottom portion of the inflatable frame and the first and second structural members define an opening in the inflatable partition.Type: GrantFiled: December 15, 2021Date of Patent: January 30, 2024Assignee: The Boeing CompanyInventors: Liu Weiqiang, Zhongzhe Dong, Long Long, Daniel Wei
-
Patent number: 11550598Abstract: Systems and methods are disclosed for generating for display digital content (e.g., an advertisement, a feed item, or some other information) together with digital components (e.g., branding data for the application or the publisher of the application). When the server receives, from a user device, a digital content request, the server can determine whether the digital content request was transmitted in response to an application state being changed to an active focus. Based on determining that the digital content request is being sent in response to an application state being changed to an active focus, the server generates a response that includes digital content and one or more digital components (e.g., branding data), and transmits that response to the user device. When the user device receives the response, the user device generates for display the digital components and the digital content.Type: GrantFiled: December 13, 2019Date of Patent: January 10, 2023Assignee: Google LLCInventors: Margaret Calliope Georgiadis, Patricia Moll, Tyler Robin Pletz, Thomas Andrew Shimko, Jr., Siavash Sedigh Nejad, Sara Christine Adkins, Long Long
-
Publication number: 20220361947Abstract: The present disclosure relates to the field of microwave ablation treatment devices, and in particular, to a microwave ablation needle head and a microwave ablation needle. A microwave ablation needle head, comprising an outer tube, a cooling tube, a coaxial cable, and an electrode. The outer tube comprises a first branch tube and a second branch tube which are sequentially provided in a direction from the distal end to the proximal end of the outer tube, and the end of the first branch tube away from the second branch tube forms the distal end of the outer tube, and the material of the first branch tube is a ceramic material or a polymer material.Type: ApplicationFiled: April 8, 2020Publication date: November 17, 2022Inventors: Weizhong WANG, Long LONG
-
Publication number: 20220304669Abstract: Disclosed are a channel device for surgery and a trigger structure. It aims at improving the problem that the operational efficiency of existing channel devices for surgery is not high. The channel device for surgery includes: a binding cord configured to be wound around a metal net; and a binding wire configured to pass through the binding cord and tighten up the binding cord, so as to compress the metal net, or configured to be pulled away from the binding cord, so as to loosen the binding cord and the metal net. In the trigger structure, different first locking portions are configured to cooperate with a first engaging portion, so as to drive the trolley to slide intermittently relative to the handle, such that a second engaging portion cooperates with different second locking portions, hereby locking the sliding trolley in different positions on the handle.Type: ApplicationFiled: April 15, 2020Publication date: September 29, 2022Inventors: Derong LENG, Zhuhai LV, Wenqi LV, Changqing LI, Long LONG, Jianyu WEI, Chengwei TANG, Li DING
-
Publication number: 20220213683Abstract: An inflatable partition includes a flexible membrane, an inflatable frame, and a support member coupled to the inflatable frame. The inflatable frame extends along a periphery of the flexible membrane and has an inner edge adjacent to the flexible membrane and an outer edge. The inflatable frame further includes a sealing mechanism extending along at least a portion of the outer edge and the inflatable frame is inflatable between a first state and a second state. The inflatable partition includes a first structural member and a second structural member. Each of the first and second structural members is coupled to the inflatable frame and extends vertically from the upper portion to the bottom portion of the inflatable frame and the first and second structural members define an opening in the inflatable partition.Type: ApplicationFiled: December 15, 2021Publication date: July 7, 2022Applicant: The Boeing CompanyInventors: Liu Weiqiang, Zhongzhe Dong, Long Long, Daniel Wei
-
Publication number: 20210373912Abstract: Systems and methods are disclosed for generating for display digital content (e.g., an advertisement, a feed item, or some other information) together with digital components (e.g., branding data for the application or the publisher of the application). When the server receives, from a user device, a digital content request, the server can determine whether the digital content request was transmitted in response to an application state being changed to an active focus. Based on determining that the digital content request is being sent in response to an application state being changed to an active focus, the server generates a response that includes digital content and one or more digital components (e.g., branding data), and transmits that response to the user device. When the user device receives the response, the user device generates for display the digital components and the digital content.Type: ApplicationFiled: December 13, 2019Publication date: December 2, 2021Inventors: Margaret Calliope Georgiadis, Patricia Moll, Tyler Robin Pletz, Thomas Andrew Shimko, Jr., Siavash Sedigh Nejad, Sara Christine Adkins, Long Long
-
Patent number: 10196346Abstract: The present invention pertains to the field of pharmaceutical chemicals, and relates to a substituted acethydrazide derivative, preparation method and use thereof; preferably, relates to a compound of Formula I or a pharmaceutically acceptable salt thereof. The compound of the present invention or a pharmaceutically acceptable salt thereof can effectively inhibit proline hydroxylase, stabilize HIF-?, particularly HIF-1?, and has potency in the manufacture of a medicament for treatment and/or prophylaxis and/or adjuvant therapy of anemia, acute ischemic reperfusion injury.Type: GrantFiled: November 20, 2017Date of Patent: February 5, 2019Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Song Li, Junhai Xiao, Lili Wang, Long Long, Wei Li, Haoming Luo, Feifei Li, Wu Zhong, Zhibing Zheng, Yunde Xie, Xingzhou Li, Xinbo Zhou, Xiaokui Wang, Ruiyuan Cao
-
Publication number: 20180134653Abstract: The present invention pertains to the field of pharmaceutical chemicals, and relates to a substituted acethydrazide derivative, preparation method and use thereof; preferably, relates to a compound of Formula I or a pharmaceutically acceptable salt thereof. The compound of the present invention or a pharmaceutically acceptable salt thereof can effectively inhibit proline hydroxylase, stabilize HIF-?, particularly HIF-1?, and has potency in the manufacture of a medicament for treatment and/or prophylaxis and/or adjuvant therapy of anemia, acute ischemic reperfusion injury.Type: ApplicationFiled: November 20, 2017Publication date: May 17, 2018Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Song LI, Junhai XIAO, Lili WANG, Long LONG, Wei LI, Haoming LUO, Feifei LI, Wu ZHONG, Zhibing ZHENG, Yunde XIE, Xingzhou LI, Xinbo ZHOU, Xiaokui WANG, Ruiyuan CAO
-
Publication number: 20170190656Abstract: The present invention pertains to the field of pharmaceutical chemicals, and relates to a substituted acethydrazide derivative, preparation method and use thereof; preferably, relates to a compound of Formula I or a pharmaceutically acceptable salt thereof. The compound of the present invention or a pharmaceutically acceptable salt thereof can effectively inhibit proline hydroxylase, stabilize HIF-?, particularly HIF-1?, and has potency in the manufacture of a medicament for treatment and/or prophylaxis and/or adjuvant therapy of anemia, acute ischemic reperfusion injury.Type: ApplicationFiled: May 20, 2015Publication date: July 6, 2017Applicant: Institute of Pharmacology and Toxicology Academy of Millitary Medical Sciences P.L.A. ChinaInventors: Song LI, Junhai XIAO, Lili WANG, Long LONG, Wei LI, Haoming LUO, Feifei LI, Wu ZHONG, Zhibing ZHENG, Yunde XIE, Xingzhou LI, Xinbo ZHOU, Xiaokui WANG, Ruiyuan CAO
-
Patent number: 9683988Abstract: The present invention provides a cell model and a method for screening c-Fms tyrosine kinase inhibitors. Specifically, the present invention provides a cell that expresses macrophage colony stimulating factor receptor and STAT1 protein simultaneously. The present invention further provides a method for screening c-Fms tyrosine kinase inhibitors, a method for evaluating the inhibiting activity of a compound or a composition against c-Fms tyrosine kinase, and use of the cell in screening c-Fms tyrosine kinase inhibitors. The cell model established in the present invention is sensitive, highly effective and reliable, and can be used in high-throughput screening and/or high-content screening of c-Fms tyrosine kinase inhibitors.Type: GrantFiled: March 14, 2012Date of Patent: June 20, 2017Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Lili Wang, Shengqian Yang, Long Long, Junhai Xiao, Song Li
-
Patent number: 9439881Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.Type: GrantFiled: October 26, 2015Date of Patent: September 13, 2016Assignee: CHINESE PLA GENERAL HOSPITALInventors: Kunlun He, Song Li, Wu Zhong, Juan Liu, Lili Wang, Xin Li, Guoliang Hu, Jie Wang, Long Long, Junhai Xiao, Zhibing Zheng, Wei Li, Ruijun Li, Chunlei Liu, Jie Tang
-
Patent number: 9260384Abstract: A compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, is provided. Also, a composition containing a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents, is provided. Further, use of a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof for anti-apoptosis is provided, preventing or treating a disease or disorder associated with apoptosis; especially for protecting cardiomyocyte, preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.Type: GrantFiled: May 14, 2010Date of Patent: February 16, 2016Assignee: Chinese PLA General HospitalInventors: Kunlun He, Song Li, Wu Zhong, Juan Liu, Lili Wang, Xin Li, Guoliang Hu, Long Long, Junhai Xiao, Zhibing Zheng, Wei Li, Ruijun Li, Chunlei Liu, Jie Bai
-
Publication number: 20160038445Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.Type: ApplicationFiled: October 26, 2015Publication date: February 11, 2016Inventors: Kunlun HE, Song LI, Wu ZHONG, Juan LIU, Lili WANG, Xin LI, Guoliang HU, Jie WANG, Long LONG, Junhai XIAO, Zhibing ZHENG, Wei LI, Ruijun LI, Chunlei LIU, Jie TANG
-
Patent number: 9199978Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.Type: GrantFiled: May 14, 2010Date of Patent: December 1, 2015Assignee: CHINESE PLA GENERAL HOSPITALInventors: Kunluu He, Song Li, Wu Zhong, Juan Liu, Lili Wang, Xin Li, Guoliang Hu, Jie Wang, Long Long, Junhai Xiao, Zhibing Zheng, Wei Li, Ruijun Li, Chunlei Liu, Jie Tang